A preliminary report on the safety and pharmacokinetics of ibogaine

Deborah C. Mash, R. Douyon, William Lee Hearn, Nancy C. Sambol, Juan Sanchez‐ramos

Biological Psychiatry May 1, 1995 Peer reviewed DOI: 10.1016/0006-3223(95)94624-6 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Pharmacokinetics Pharmacology Medicine

Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress Journal of Psychoactive Drugs • January 2, 2026 • via OpenAlex
A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model Scientific Reports • November 26, 2025 • via OpenAlex
Treating War Trauma with Ibogaine and 5-MEO-DMT June 16, 2025 • via OpenAlex
Pharmacokinetics of Psilocybin: A Systematic Review Pharmaceutics • March 25, 2025 • via OpenAlex

Comments

No comments yet.

Log in to comment